National and Kapodistrian University of Athens
Investigation of the role of microglia and macrophages in remyelination and repair of the central nervous system, to enhance their beneficial function, as new therapeutic strategy for multiple sclerosis
Abstract
dc:descriptionIn demyelinating neurodegenerative disorders, including the autoimmune neuroinflammatory disease Multiple Sclerosis (MS), remyelination -the endogenous reparative process of the CNS- gradually fails, leading to irreversible neurological deficits. Microglia, the CNS-resident immune cells, play a critical role in both demyelination and remyelination by shaping the CNS environment. In this study pharmacological and conditional gene-targeting tools in mice, combined with single-cell and bulk brain transcriptomics, immunofluorescent 3D brain imaging, and functional motor performance tests, were applied in in vivo and in vitro experimental models of MS, to dissect the cellular and molecular mechanisms that regulate microglia-mediated CNS remyelination with the aim to identify potential therapeutic targets to enhance remyelination and CNS repair. Pharmacological inhibition of the major pro-inflammatory cytokine soluble TNF (solTNF) using XPro1595, a selective brain-penetrant inhibitor, promoted cortical remyelination and oligodendrocyte progenitor’s maturation in a Cuprizone-induced demyelination model, by modulating microglia responses. Restoration of myelin and associated clinical recovery were further validated in a second MS model, experimental autoimmune encephalomyelitis (EAE). Additionally, spatial and temporal conditional gene editing using the tamoxifen-inducible Cx3cr1-CreER genetic system revealed that microglia-specific therapeutic deletion of TNF receptor 1 (TNFR1) the main receptor for solTNF, in contrast to TNFR2 the main receptor of transmembrane TNF, was sufficient to promote cortical remyelination and improve functional motor performance, demonstrating a beneficial cell-autonomous role of microglia in the absence of TNFR1. Phenotypic analysis of cortical microglia revealed an altered microglia polarization characterized by highly-activated morphology, beneficial Arginase-1 expression and enhanced interactions with neurons and astrocytes in the absence of the solTNF-TNFR1 axis, along with improved phagocytic clearance of myelin debris, a critical microglia function for OPC recruitment and remyelination. Furthermore, microglia ablation using the CSF1R inhibitor PLX3397 after the peak of Cuprizone-induced demyelination impaired myelin recovery, highlighting the essential contribution of microglia to CNS remyelination. Longitudinal brain RNA sequencing throughout disease progression and resolution revealed distinct brain transcriptomic signatures associated with demyelination and remyelination, with earlier recovery observed upon therapeutic microglia TNFR1 deletion. Single-cell transcriptomics of cortical microglia at disease onset revealed that disease-associated microglia (DAM) maintained an IL-10-reparative inflammatory phenotype instead of switching to a default IL-1-related damaging profile, in the absence of solTNF. The functional relevance of the identified molecular targets for microglia polarization was further validated in vivo. Microglia-specific genetic deletion of the IL-10 receptor (IL-10RA) in the Cuprizone-induced demyelination model, resulted in altered cortical microglial morphology at disease onset. Meanwhile, pharmacological blockade of the IL-1 receptor with Anakinra (IL-1Ra), an FDA-approved drug, reproduced the pro-remyelinating effects of microglia, observed with solTNF inhibition, in cortical Cuprizone-experimental demyelination. Disease-state microglia producing downstream IL-1/IL-18/CASP1 targets were identified in human MS and neuromyelitis optica (NMO) demyelinating lesions. Taken together, this study demonstrates that highly-activated inflammatory microglia mediate cortical remyelination in experimental Cuprizone-demyelination, and identifies solTNF-TNFR1 as an immune checkpoint for the polarization between reparative and damaging microglia inflammatory states. Cytokine reprogramming of microglia by selective inhibitors of solTNF, TNFR1, or downstream IL-1 pathways harnesses the beneficial properties of inflammatory microglia in favor of CNS restoration. Overall, redirecting disease microglia polarization and enhancing regenerative microglia functions is a potential therapeutic strategy for promoting remyelination in CNS demyelinating disorders.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Boutou, Athina
- Μπούτου, Αθηνά
Subjects
dc:subject × 16Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59233